Valproic Acid and the Liver Injury in Patients with Epilepsy: An update.
CONCLUSION: Therapeutic drug monitoring (TDM) and routine liver biochemistry monitoring during VPA-therapy, as well as genotype screening for certain patients before VPA administration, could improve the safety profile of this antiepileptic drug.
PMID: 30931853 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Guo HL, Jing X, Sun JY, Hu YH, Xu ZJ, Nie MM, Chen F, Lu XP, Qiu JC, Wang T Tags: Curr Pharm Des Source Type: research